[Recurrence of hepatocellular carcinoma associated with hepatitis C virus after tumor ablation].
Sakaguchi
Kohsaku
K
Department of Gastroenterology and Hepatology, Okayama University Graduate School.
Kobayashi
Yoshiyuki
Y
Matsumoto
Eiichi
E
Shiratori
Yasushi
Y
D000998:Antiviral Agents; D006528:Carcinoma, Hepatocellular / Q000209:etiology / Q000628:therapy*; D017115:Catheter Ablation; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D000431:Ethanol / Q000008:administration & dosage; D006498:Hepatectomy; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D015552:Injections, Intralesional; D016898:Interferon-alpha / Q000008:administration & dosage; D008113:Liver Neoplasms / Q000209:etiology / Q000628:therapy*; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology / Q000517:prevention & control*; D011379:Prognosis; D012254:Ribavirin / Q000008:administration & dosage; D012307:Risk Factors; D013997:Time Factors
D000998:Antiviral Agents; D016898:Interferon-alpha; D000431:Ethanol; D012254:Ribavirin